MediPal Holdings Corporation (MEPDF)
OTCMKTS · Delayed Price · Currency is USD
15.90
0.00 (0.00%)
Sep 24, 2025, 8:00 PM EDT
MediPal Holdings Market Cap
MediPal Holdings has a market cap or net worth of $3.63 billion as of September 26, 2025. Its market cap has decreased by -0.37% in one year.
Market Cap
3.63B
Enterprise Value
2.92B
Revenue
25.69B
Ranking
n/a
PE Ratio
12.81
Stock Price
$15.90
Market Cap Chart
Since June 30, 1999, MediPal Holdings's market cap has increased from 393.25M to 3.63B, an increase of 822.65%. That is a compound annual growth rate of 8.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 3.61B | 14.48% |
| Dec 30, 2024 | 3.15B | -8.04% |
| Dec 29, 2023 | 3.42B | 23.56% |
| Dec 30, 2022 | 2.77B | -29.46% |
| Dec 30, 2021 | 3.93B | -0.23% |
| Dec 30, 2020 | 3.94B | -15.37% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Tian'an Technology Group | 718.73M |
| Elite Pharmaceuticals | 686.78M |
| Glass House Brands | 541.39M |
| Northwest Biotherapeutics | 375.87M |
| CytoDyn | 358.21M |
| American Oncology Network | 335.84M |
| Nika Pharmaceuticals | 301.74M |